Showing results (1151-1160 of 1,667) with videos related to

Sort By:
Pageof 167
American Journal of Respiratory and Critical Care Medicine|December 1, 2021
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled TrialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Rheumatology|January 30, 2010
Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trialsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 7, 2012
The asthma ePrompt: a novel electronic solution for chronic disease managementKaiser G Lim, Matthew A Rank, Rosa L Cabanela, et al.
Meat Science|December 14, 2020
Shiga toxin-producing Escherichia coli (STEC) in bovine meat and meat products over the last 15 years in Brazil: A systematic review and meta-analysisDébora Cristina Sampaio de Assis, Thaís Michelle Liziere da Silva, Rommel Furst Brito, et al.
Clinical Rheumatology|September 8, 2019
The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA)N Barroso, T G Woodworth, D E Furst, et al.
JACC. Advances|April 23, 2026
Systemic Inflammation and Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Chronic Kidney DiseaseAlexander T Sandhu, Adam Furst, Fatima Rodriguez, et al.
Cutis|December 28, 2002
Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosisJoseph Jorizzo, Daniel Stewart, Alicia Bucko, et al.
The Journal of Rheumatology|May 5, 2007
Systemic sclerosis - continuing progress in developing clinical measures of responseDaniel Furst, Dinesh Khanna, Marco Matucci-Cerinic, et al.
The Journal of Rheumatology|October 7, 2003
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritisDaniel E Furst, Michael Weisman, Harold E Paulus, et al.
Pageof 167